GGrantIndex
← Leaderboards

Santanu Bose

Medical College Of Wisconsin

$4,095,641
Attributed
$4,310,110
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $375.2K · FY200721
$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$4,310,110 · 5

By mechanism

R01$3,143,915 · 1
R21$1,154,921 · 3
P41$11,274 · 1

Top collaborators

Most similar at Medical College Of Wisconsin

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionMediatingRespiratory SystemChildResponsePlayVirus DiseasesPathogenIn VivoCellsPathway InteractionsVirusProteinsReportingInfectionEpithelial CellsInfantCytokineMorbidity - Disease RateElderlyLungRespiratory Syncytial VirusBronchiolitisInflammation

Grant awards (18)

Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infection$375,233
R01 · FY2021 · AI · contact PI
Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infection$375,233
R01 · FY2020 · AI · contact PI
Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infection$375,233
R01 · FY2019 · AI · contact PI
Molecular and cellular mechanism regulating innate immunity and inflammation during pattern recognition receptor activation and respiratory virus infection$375,233
R01 · FY2018 · AI · contact PI
Mycoplasma pneumoniae CARDS toxin mediated ADP-ribosylation of NLRP3 inflammasome$189,688
R21 · FY2016 · AI
Mycoplasma pneumoniae CARDS toxin mediated ADP-ribosylation of NLRP3 inflammasome$239,250
R21 · FY2015 · AI
Host defense against respiratory virus infections$336,353
R01 · FY2014 · AI · contact PI
Host defense against respiratory virus infections$243,805
R01 · FY2013 · AI · contact PI
Host defense against respiratory virus infections$67,132
R01 · FY2013 · AI · contact PI
Host defense against respiratory virus infections$330,784
R01 · FY2012 · AI · contact PI
Host defense against respiratory virus infections$330,784
R01 · FY2011 · AI · contact PI
Host defense against respiratory virus infections$334,125
R01 · FY2010 · AI · contact PI
Oncolytic activity of respiratory syncytial virus against prostate cancer$200,250
R21 · FY2009 · CA · contact PI
Anti viral function of interferon alpha induced human beta defensin 3$179,033
R21 · FY2008 · AI · contact PI
Oncolytic activity of respiratory syncytial virus against prostate cancer$166,500
R21 · FY2008 · CA · contact PI
Anti viral function of interferon alpha induced human beta defensin 3$180,200
R21 · FY2007 · AI · contact PI
DIMERIZATION OF TRANSCOBALAMIN II RECEPTOR$0
P41 · FY2001 · RR
DIMERIZATION OF TRANSCOBALAMIN II RECEPTOR$11,274
P41 · FY2000 · RR